Prostate Cancer - Results from #100

Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay. June 8, 2022

Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial). June 8, 2022

External beam radiation therapy treatment factors prognostic of biochemical failure free survival: a multi-institutional retrospective study for prostate cancer. June 8, 2022

Metastasis-free survival and patterns of distant metastatic disease after PSMA-PET-guided salvage radiotherapy in recurrent or persistent prostate cancer after prostatectomy. June 8, 2022

The survival outcomes of very young and elderly patients with high-risk prostate cancer after radical treatments: A population-matched study. June 7, 2022

Neoadjuvant Chemohormonal Therapy in Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis. June 7, 2022

[Recent advances in the management of localized high-risk prostate cancer: An update by the Prostate Cancer Committee of the French Association of Urology]. June 7, 2022

Absolute Percentage of Pattern 4 Disease as a Prognostic Measure for Intermediate-risk Prostate Cancer Treated with Stereotactic Body Radiotherapy. June 7, 2022

Diagnostic value of multiparametric MRI in detecting residual or recurrent prostate cancer after high-intensity focused ultrasound. June 7, 2022

Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data. June 6, 2022

DNA damage repair gene germline profiling for metastatic prostate cancer patients of different ancestries. June 6, 2022

Second malignancy probabilities in patients with prostate cancer treated with whole pelvis radiation therapy versus prostate only radiation therapy. June 6, 2022

Rates of metastatic prostate cancer in newly diagnosed patients: Numbers needed to image according to risk level. June 6, 2022

Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [177Lu]Lu-PSMA I&T during long-term follow-up. June 6, 2022

Statin and metformin use and outcomes in patients with castration-resistant prostate cancer treated with enzalutamide: A meta-analysis of AFFIRM, PREVAIL and PROSPER. June 3, 2022

Prostate Cancer Treatment: 177Lu-PSMA-617 Considerations, Concepts, and Limitations. June 3, 2022

Assessing the impact of brachytherapy boost and androgen deprivation therapy on survival outcomes for patients with unfavorable intermediate-risk prostate cancer patients treated with external beam radiotherapy. June 3, 2022

Salvage Prostate Stereotactic Body Radiation Therapy After Definitive Cryoablation. June 3, 2022

The Long-Term Effect of Intensity Modulated Radiation Therapy for Prostate Cancer on Testosterone Levels. June 3, 2022

First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the Literature. June 3, 2022

Page 6 of 1232

email news signup